Context Therapeutics Inc

FRA:6K9 (USA)  
€ 1.83 (+1.67%) May 29
At Loss
P/B:
3.91
Market Cap:
€ 138.22M ($ 149.53M)
Enterprise V:
€ 115.06M ($ 124.48M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Context Therapeutics Inc Valuation Measures